Daniel Grosslight

Q: What is Daniel Grosslight's success rate?

Daniel Grosslight currently has a success rate of 93.26294184221162.

Q: What is the average return of Daniel Grosslight's calls?

Their stock ratings have generated an average return of 12.47958274579638.

Citigroup | Healthcare

Daniel Grosslight is an analyst from Citigroup specializing in the Healthcare sector. Ranked #1036 out of 4620 analysts, they have issued 44 stock ratings with a success rate of 93.26% and an average return of 12.48%.

Daniel Grosslight has a well-established track record, with 44 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 93.26% and an average return of 12.48%, underscoring their expertise and ability to identify winning opportunities for investors.

#1036

Out of 4620

Total Ratings

+93.26%

Success Rate

+12.48%

Average Return

Recent Ratings Analysis

ALGN

Buy

Apr 15, 2026

Target

$240.00

Current

$184.69

Performance

—

Daniel Grosslight rated ALGN as Buy on Apr 15, 2026, setting a price target of 240. Shares have remained stable near 184.69, leaving the 240 target still in play.

ZTS

Buy

Apr 15, 2026

Target

$145.00

Current

$121.11

Performance

—

On Apr 15, 2026, ZTS was given a Buy rating by Daniel Grosslight, with a target price of 145. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

XRAY

Sell

Apr 15, 2026

Target

$10.00

Current

$12.22

Performance

—

XRAY received a Sell rating from Daniel Grosslight on Apr 15, 2026, aiming for 10. Bearish momentum failed to push shares lower, as they hovered around 12.22.

PAHC

Hold

Apr 15, 2026

Target

$62.00

Current

$59.02

Performance

—

On Apr 15, 2026, Daniel Grosslight published a Neutral outlook on PAHC, with a target of 62. Sideways action left the Hold view intact, with no major move since 59.02.

NVST

Hold

Apr 15, 2026

Target

$29.00

Current

$27.38

Performance

—

Daniel Grosslight on Apr 15, 2026 assigned NVST a Neutral rating, with a price target of 29. The Hold stance reflected consolidation, as shares held near 27.38.

IDXX

Hold

Apr 15, 2026

Target

$650.00

Current

$584.05

Performance

—

On Apr 15, 2026, Daniel Grosslight reaffirmed IDXX with a Neutral rating, targeting 650. The neutral call matched muted market action of %.

HSIC

Buy

Apr 15, 2026

Target

$100.00

Current

$77.20

Performance

—

HSIC was rated Buy by Daniel Grosslight on Apr 15, 2026, with a price objective of 100. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

ELAN

Buy

Apr 15, 2026

Target

$30.00

Current

$24.11

Performance

—

On Apr 15, 2026, Daniel Grosslight initiated coverage on ELAN with a Buy rating and target of 30. Neutral price movement of % leaves room for interpretation.

PHR

Hold

Mar 31, 2026

Target

$10.00

Current

$8.60

Performance

2.63%

Daniel Grosslight issued a Neutral recommendation for PHR on Mar 31, 2026, price target set at 10. The rating was appropriate for a consolidating market trading near 8.6.

HCAT

Hold

Mar 13, 2026

Target

$1.75

Current

$1.12

Performance

-15.15%

On Mar 13, 2026, HCAT was evaluated by Daniel Grosslight, who gave a Neutral rating and target of 1.75. The Hold call avoided chasing into subsequent weakness of 15.15%.

HIMS

Hold

Mar 10, 2026

Target

$24.00

Current

$21.36

Performance

-8.99%

Daniel Grosslight rated HIMS as Neutral on Mar 10, 2026, setting a price target of 24. The cautious Hold call aligned with subsequent weakness, as shares slipped 8.99%.

TDOC

Hold

Mar 03, 2026

Target

$9.00

Current

$5.24

Performance

2.75%

On Mar 03, 2026, TDOC was given a Neutral rating by Daniel Grosslight, with a target price of 9. Market indecision, reflected in sideways trading near 5.24, supported the cautious call.

PRVA

Buy

Mar 03, 2026

Target

$34.00

Current

$23.12

Performance

-2.73%

PRVA received a Buy rating from Daniel Grosslight on Mar 03, 2026, aiming for 34. Price action was muted, as shares hovered around 23.12 despite the bullish outlook.

GDRX

Buy

Mar 03, 2026

Target

$4.50

Current

$2.23

Performance

7.73%

On Mar 03, 2026, Daniel Grosslight published a Buy outlook on GDRX, with a target of 4.5. Shares gained 7.73%, underscoring the accuracy of the bullish outlook toward 4.5.

AGL

Hold

Mar 03, 2026

Target

$0.85

Current

$22.68

Performance

59.89%

Daniel Grosslight on Mar 03, 2026 assigned AGL a Neutral rating, with a price target of 0.85. Shares outperformed expectations, climbing 59.89% despite the neutral view.

EVH

Buy

Feb 26, 2026

Target

$6.00

Current

$2.51

Performance

-24.40%

On Feb 26, 2026, Daniel Grosslight reaffirmed EVH with a Buy rating, targeting 6. Shares slid 24.40% despite the recommendation, highlighting downside risks.

CTEV

Buy

Feb 25, 2026

Target

$63.00

Current

$18.14

Performance

22.40%

CTEV was rated Buy by Daniel Grosslight on Feb 25, 2026, with a price objective of 63. A bullish response from the market helped close the gap of 44.86 to the target.

WAY

Buy

Feb 18, 2026

Target

$46.00

Current

$22.43

Performance

-11.73%

On Feb 18, 2026, Daniel Grosslight initiated coverage on WAY with a Buy rating and target of 46. The Buy call has yet to be validated as shares remain 23.57 away from the target.

CAH

Buy

Jan 09, 2026

Target

$244.00

Current

$214.95

Performance

6.88%

Daniel Grosslight issued a Buy recommendation for CAH on Jan 09, 2026, price target set at 244. Investors following the Buy call captured upside momentum, with shares now at 214.95.

MCK

Buy

Sep 24, 2025

Target

$860.00

Current

$862.79

Performance

13.44%

On Sep 24, 2025, MCK was evaluated by Daniel Grosslight, who gave a Buy rating and target of 860. This case illustrates how a timely bullish rating can translate into tangible gains of 13.44%.

OMI

Buy

Aug 12, 2025

Target

$7.00

Current

$2.68

Performance

-51.01%

Daniel Grosslight rated OMI as Buy on Aug 12, 2025, setting a price target of 7. The stock has underperformed, dropping 51.01% despite the bullish target of 7.

MPLN

Hold

Jan 10, 2025

Target

$12.50

Current

$23.15

Performance

81.85%

On Jan 10, 2025, MPLN was given a Neutral rating by Daniel Grosslight, with a target price of 12.5. The stock rallied from 23.15 to 23.15 after the Hold rating, surprising to the upside.

Frequency Asked Questions

Who is Daniel Grosslight?

Daniel Grosslight is an analyst from Citigroup specializing in the Healthcare sector.

What is Daniel Grosslight's success rate?

Daniel Grosslight currently has a success rate of +93.26%.

How many ratings has Daniel Grosslight issued?

Daniel Grosslight has issued 44 stock ratings so far.

What is the average return of Daniel Grosslight's calls?

Their stock ratings have generated an average return of +12.48%.

What is Daniel Grosslight's ranking?

Daniel Grosslight is ranked #1036 out of 4620 analysts.

What types of ratings does Daniel Grosslight give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Daniel Grosslight?

You can follow Daniel Grosslight by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Daniel Grosslight?

Their latest rating was a Buy on ALGN issued on 2026-04-15.